Cure for Certain Cancers Is Realistic Goal in Next Decade, Pharma Lead Says

Johnson & Johnson CEO stated that curing certain cancers is a realistic goal for the next decade, citing progress in multiple myeloma and immunotherapy. This optimism reflects significant advancements in medical science that could drastically reduce cancer mortality rates. The industry's commitment to these goals suggests a new era of breakthrough treatments is on the horizon.